NCT01127295 2026-04-14
PHACS
Institut Claudius Regaud
Phase 4 Completed
Clinical Trials
6 trialsNCT01553903 2026-04-14
OXYTAM
Institut Claudius Regaud
Phase 4 Completed
NCT01612871 2026-04-14
MIRHO
Institut Claudius Regaud
Phase 4 Completed
NCT05161195 2026-04-02
Roll-over Study to Allow Continued Access to Ribociclib
Novartis
Phase 4 Active not recruiting
NCT06143631 2026-02-03
PLUM
University of California, San Francisco
Phase 4 Recruiting
NCT05183828 2026-01-26
Effect of HSD3B1 (1245C) Gene Mutation on Treatment of Stage I-III Breast Cancer
University of Washington
Phase 4 Recruiting